Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function.
Shawn J MachaBalakrishna KoneruTrevor A BurrowCharles ZhuDzmitry SavitskiRakhshanda L RahmanCatherine A RonaghanJonas NanceKristyn McCoyCody EslingerC Patrick ReynoldsPublished in: Cancer research (2022)
This work demonstrates that constitutive activation of ATM in chemotherapy-refractory ALT cancer cells renders them hypersensitive to reactivation of p53 function by APR-246, indicating a potential strategy to overcome therapeutic resistance.